Industry leader and multi-omics pioneer joins leadership team to advance AI-driven solutions
Gent, Belgium – 17th November, 2025. BioLizard, a leader in multi-omics integration and AI-powered biopharma analytics, is pleased to announce the appointment of Dr. Alexander Scheer as Chief Scientific Officer (CSO). Dr. Scheer is a highly respected...
BioLizard Logs Stellar First Half of 2025: Growth, Innovation & Recognition
As we gear up for the final stretch of the year, BioLizard enters the autumn season with renewed energy and momentum. The company has delivered a standout first half of 2025, marked by international recognition, groundbreaking AI innovation, and strategic expansion....
BioLizard Awarded Grant from VLAIO to Advance AI-Powered Biomedical Solution for Accelerated Drug Development
VLAIO grant to fund development of new AI application, using large language models (LLMs) to search, extract and structure key insights from vast scientific datasets, significantly reducing review time and knowledge extraction State-of-the-art solution will further...
BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biotech Showcase during JP Morgan Week (Jan 13-15, 2025) in San...